causal

Cancer Drug Stampede Driven by Exclusivities

There is a stampede into cancer drugs inspired by exclusivities available there but not elsewhere, producing many extraordinarily expensive drugs that extend life by only a month or two—or not at all—which makes no economic sense and reflects companies chasing where the regulatory returns are highest rather than where value is greatest.

causalpending

Speaker

Robin Feldman

Evidence Quote

“you see a lot of drugs that have very little effect, if any--maybe extending life for a month or two, or maybe not--but extraordinarily expensive.”

Source

Robin Feldman on Drugs, Money, and Secret Handshakes— EconTalk
Created: 6/13/2026, 12:12:41 AM

Your notes

Loading notes...